Trump's New AI Executive Order Will Spark a $10 Trillion Boom

On July 23, 2025, Trump launched America's AI Action Plan to secure global tech dominance. Morgan Stanley calls it a $10T boom. It's the closest thing to a government-backed wealth transfer-and your chance to get in early.

FDA warns websites selling unapproved Botox for cosmetic purposes

MATTHEW PERRONE
November 05, 2025

Associated Press (AP) -- U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth wrinkles.

The Food and Drug Administration said it was taking action after receiving reports of injuries in connection with the products, including toxic side effects.

Botox is a diluted, purified form of botulinum, one of the most toxic substances in the world. The ingredient works by temporarily blocking nerve signals and causing muscles to relax. While most famously approved for cosmetic use, Botox is also approved in the U.S. for a number of medical conditions, including muscle spasms, eye disorders and migraines.

The FDA warning letters mostly went to cosmetic websites. In each case, the FDA said the companies were offering unofficial or mislabeled versions of Botox-like drugs that haven't been approved by the agency. In addition to the original drug, introduced by Allergan in 1989, the FDA has approved several competing versions.

FDA-approved Botox drugs carry the agency's most serious warning, a boxed label alerting doctors and patients that the medications can cause serious or life-threatening side effects.

In rare cases, the toxin can spread beyond the injection site to other parts of the body, paralyzing or weakening muscles needed for breathing and swallowing. Signs of botulism include difficulty swallowing or breathing, slurred speech and muscle weakness. Those symptoms can occur several hours after an injection.

In a press release Wednesday, the FDA said patients should only receive the drugs from health professionals who are licensed and trained to administer them. Patients experiencing signs of botulism should "seek immediate medical care," the agency noted.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Continue Reading...

Popular

Anthony Scaramucci Calls Zohran Mamdani's Win An 'Anger-Based Reaction' To Boomer Policies, Says New NYC Mayor Could Become 'Popular' If...

Anthony Scaramucci, the founder of SkyBridge Capital, described Zohran Mamdani’s victory in New York City's mayoral race as an “anger-based reaction” by the young people against the policies of the boomer generation's political elites.

IRS Direct File won't be available next year. Here's what that means for taxpayers

WASHINGTON (AP) — IRS Direct File, the electronic system for filing tax returns for free, will not be offered next year, the Trump administration has confirmed.

Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad

You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1

Hedera Gets Its First ETF: Canary's HBAR Fund Lets Investors Tap Into The Tokenization Boom

Canary Capital Group’s new fund, the Canary HBAR ETF (NASDAQ:HBR), launched on Oct 28, marking a significant expansion of investors’ access to digital assets outside of Bitcoin and Ethereum.

Wingstop CEO Flags Broadening Demand Weakness, Cuts Outlook

Wingstop (NASDAQ: WING) shares surge on mixed Q3 results, with earnings beating expectations while revenue falls short.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Dave Ramsey Reveals Why Millionaires Crush Mortgages Early

Dave Ramsey advises buying a home with cash, citing his firm's survey of millionaires who often retire their mortgages in about 10 years.

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Zohran Mamdani Wins NYC Mayor Race, Abigail Spanberger Becomes Virginia's First Female Governor In Historic Democratic Win (UPDATED)

U.S. stock futures slipped on election night as Democrat Abigail Spanberger made history by becoming Virginia's first female governor, signaling a major political shift while markets reacted to post-election uncertainty.

Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It

November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.

From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad

Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.

Coeur Mining's $7 Billion Deal For New Gold Creates $20 Billion Powerhouse

Coeur Mining Inc. (CDE) announced acquisition of New Gold Inc. (NGD) in all-stock deal valued at $7 billion.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

OpenAI and Amazon sign $38B deal for AI computing power

SEATTLE (AP) — OpenAI and Amazon have signed a $38 billion deal that enables the ChatGPT maker to run its artificial intelligence systems on Amazon's cloud computing services.

Shutdown stalemate set to drag into sixth week as Trump pushes Republicans to change Senate rules

WASHINGTON (AP) — Republicans and Democrats remained at a stalemate on the over the weekend as it headed into its sixth week, with for millions of Americans and President Donald Trump pushing GOP leaders to change Senate rules to end it.

Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad

Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.

Tempus AI Stock (TEM) Slides 6% Overnight: Here's Why The Stock Is Trending

Tempus AI shares fell 6.02% in after-hours trading Tuesday following its third-quarter earnings report.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.

Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading?

MediciNova shares soared over 87% in after-hours trading on Thursday following the publication of promising research.

Trump tariffs face Supreme Court test in trillion-dollar test of executive power

WASHINGTON (AP) — President power to unilaterally impose far-reaching is coming before the Supreme Court on Wednesday in a pivotal test of executive power with trillion-dollar implications for the global economy.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Bitcoin's Downtrend Explained By Wall Street Vet: It's An 'IPO-Style Distribution'

Veteran Wall Street investor Jordi Visser said on Anthony Pompliano's podcast that the current Bitcoin (CRYPTO: BTC) price action resembles an "

Trump's Next Ban - Coming January 19, 2026 (shocking) - Ad

On Jan 19, 2026, Trump is expected to sign an order banning exports of a material every tech firm needs. Not chips-but without it, tech stops. It's his move for U.S. tech dominance. $2T already committed by giants like Apple and NVIDIA. Weeks remain to position before the shift.

Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades

Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the stock to Outperform.

Zohran Mamdani Was Crypto Bettors' Overwhelming Favorite For New York City Mayor At 100% Odds — And He Just Won

Zohran Mamdani won the high-stakes New York City mayoral race Tuesday,  a victory widely anticipated by cryptocurrency bettors, who had overwhelmingly backed the Democratic Socialist.

Trump's New AI Executive Order Will Spark a $10 Trillion Boom - Ad

On July 23, 2025, Trump launched America's AI Action Plan to secure global tech dominance. Morgan Stanley calls it a $10T boom. It's the closest thing to a government-backed wealth transfer-and your chance to get in early.

Jim Cramer Warns 'Don't Be Fooled' Because Speculators In Gold, Quantum And Nuclear Energy Aren't Going Down 'Without A Fight'

Former hedge fund manager and renowned CNBC TV host Jim Cramer is sounding the alarm on certain speculative pockets of the market, urging investors to sell into the "snapback" momentum if they haven't already done so.

S&P Global Boosts Outlook As CEO Hails Exceptional Growth

S&P Global (NYSE: SPGI) shares surge after reporting strong Q3 results, beating expectations with adjusted earnings of $4.73 per share.

Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad

You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1

Pete Hegseth Says War Department Preparing For 'Action' In Nigeria

U.S. Defense Secretary Hegseth agrees with Trump's order to prepare for action in Nigeria to stop the killing of Christians by Islamist militants.

Taylor Swift, Elon Musk, Donald Trump, MrBeast — Robinhood Just Made Their Mojo Tradable

Robinhood has new prediction markets for its customers, with a focus on the entertainment sector. Here are some of the new markets.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Why Are First Solar Shares Surging On Friday?

First Solar beats Q3 sales estimates and reports record module shipments. Analyst raises price target to $150 despite supply chain challenges.

Bloom Energy Stock Surges Nearly 17% In Wednesday Pre-Market: What's Going On?

Shares of Bloom Energy Corp soared 18.68% in pre-market trading on Wednesday as third-quarter results surpassed analyst estimates.

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

What to know about the deadly UPS plane crash in Kentucky

LOUISVILLE, Ky. (AP) — At least seven people are dead and 11 others injured after a caught fire and crashed Tuesday while taking off from the company's distribution hub in Louisville, leaving a trail of flames near the runway.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service